Part 2/11:
For example, the NIH owns a 50% stake in the Moderna vaccine, meaning that billions of dollars generated from vaccine sales translate into profits for the agency itself. More alarmingly, at least four to six NIH high-level deputies—working under prominent figures like Anthony Fauci—collect royalties of up to $150,000 annually, potentially forever as long as the mRNA technology remains on the market. This creates an undeniable conflict of interest, as these officials are financially incentivized to promote and approve vaccines that benefit their personal and institutional portfolios.